A Platform for Developing High-Affinity Selective Binding Proteins to Short and Flexible Peptide Motifs

Inventor(s):

    SUMMARY

    • Short and flexible peptide motifs such as GPCRs and histone tails are attractive targets for therapeutic development, but the generation of traditional antibodies against these targets remains a challenge because of unfavorable binding kinetics.
    • The inventors developed a novel affinity reagent scaffold particularly applicable to binding short and flexible peptide motifs consisting of a first capture domain that facilitates specific protein-protein interaction between the probe and target and a second enhancer domain that enhances the affinity to the target. The two connected domains work synergistically to achieve high levels of affinity and specificity that are unattainable with either domain alone. 
    • The invention is a class of binding proteins called affinity clamps, with a clamshell architecture particularly applicable for binding short peptide motifs. Directed evolution with recombinant affinity clamp libraries can produce high affinity and specific binding reagents to a wide range of targets.
    • In proof of concept experiments, affinity clamp libraries were used to explore the role of Grb2 interactions with specific phosphotyrosine motifs in PrE cell differentiation without relying on loss of function genetic knockdowns.  Affinity clamps were generated that could discriminate between similar phosphotyrosine peptide targets that bound with single digit nanomolar affinity.

     

    FIGURE

    (A)Schematic overview of the affinity clamp platform and screening process. Combinatorially diversified libraries are used to identify affinity clamps with a high affinity and specificity for a target of interest. (B) Protein ribbon structure of an affinity clamp that binds to a specific tag (yellow). The capture domain is shown in grey (PDZ) and the enhancer domain in green (FN3). 

     

    ADVANTAGES

    ADVANTAGES

    • Works on challenging epitopes not compatible with traditional antibodies
    • Highly expressible scaffold with low cost and scalable in vitro production
    • Platform technology applicable to a wide range of different targets
    • Applicable with directed evolution using both yeast and phage display

    APPLICATIONS

    • Antibody-based research assays
    • Label free biosensors
    • Affinity tag purification and pulldown assays  

    PUBLICATIONS

     

    • Issued US Patents on affinity clamps and methods of use: 9,885,050 8,263,350
    • Tangible property for material transfer (recombinant libraries)

    TECH DETAILS

    Published
    6/29/2020

    Reference ID
    06-T-018

    Have Questions?

    Michael Hinton

    Contact Michael Hinton, Senior Manager, Technology Marketing, who can provide more detail about this technology, discuss the licensing process, and connect you with the inventor.

    This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

    Accept
    [%Analytics%]